Medigoxin [medigoxin]
- Terms
-
4'''-O-Methyldigoxin
Bemecor
beta-Methyldigoxin
Lanirapid
Lanitop
Medixin
Methyldigoxin
Metildigoxin
A semisynthetic digitalis glycoside with the general properties of DIGOXIN but more rapid onset of action. Its cardiotonic action is prolonged by its demethylation to DIGOXIN in the liver. It has been used in the treatment of congestive heart failure (HEART FAILURE).
- DUI
- D008520 MeSH Browser
- CUI
- M0013272
- CAS
- Card-20(22)-enolide, 3-((O-2,6-dideoxy-4-O-methyl-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-
- Previous indexing
- Digoxin (1966-1978)
- History note
- 91(79); was see under DIGOXIN 1979-90
- Public note
- 91; was see under DIGOXIN 1979-90
Allowable subheadings
- AD
- administration & dosage 0
- AE
- adverse effects 1
- AG
- agonists 0
- AA
- analogs & derivatives 0
- AN
- analysis 0
- AI
- antagonists & inhibitors 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 0
- CL
- classification 0
- EC
- economics 0
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 0
- PK
- pharmacokinetics 1
- PD
- pharmacology 0
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 0
- TO
- toxicity 0
- UR
- urine 0